ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 930

$433K Total Retail Price of All Prescriptions

Rank: 191 out of 930

657 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Washington
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 592 556 112 1 3
LISINOPRIL 587 539 105 2 1
AMLODIPINE BESYLATE 497 462 77 3 5
LEVOTHYROXINE SODIUM 494 480 88 4 2
OMEPRAZOLE 493 403 113 5 4
POTASSIUM CHLORIDE 398 360 73 6 16
GABAPENTIN 389 297 80 7 14
LOSARTAN POTASSIUM 368 363* 58 8 11
HYDROCODONE-ACETAMINOPHEN 357 269 81 S3 9 7
METOPROLOL TARTRATE 303 279 58 10 13
CITALOPRAM HBR 295 272 46 11 17
HYDROCHLOROTHIAZIDE 294 257 52 12 10
FUROSEMIDE 289 276 57 13 8
METFORMIN HCL 246 229 50 14 9
ATORVASTATIN CALCIUM 211 198 45 15 6
ATENOLOL 176 127 30 16 15
PRAVASTATIN SODIUM 162 129 32 17 20
TRAZODONE HCL 161 137 30 18 22
LANTUS 144 130 21 19 46
METOPROLOL SUCCINATE 118 113* 26 20 18
TRAMADOL HCL 115 110* 35 21 26
GLIMEPIRIDE 114 99 21 22 55
RANITIDINE HCL 95 80 14 23 31
DIGOXIN 85 85 19 24 133
OXYCODONE HCL 85 37 14 S2 24 27
LOVASTATIN 83 78* 20 26 19
TRIAMTERENE-HCTZ 83 78* 19 26 41
DONEPEZIL HCL 78 78 11 28 34
PAROXETINE HCL 77 72* 16 29 61
CLONAZEPAM 77 25 19 B 29 49
FLUTICASONE PROPIONATE 77 72* 31 29 24
TAMSULOSIN HCL 74 74 19 32 23
METHOCARBAMOL 74 44 20 R 32 97
ALLOPURINOL 73 68* 11 34 30
PREDNISONE 71 66* 36 35 38
SPIRIVA 67 62* 14 36 48
SERTRALINE HCL 67 44 15 36 21
GLIPIZIDE 61 56* 11 38 43
CYMBALTA 59 <11 <11 39 52
MELOXICAM 59 54* 22 39 53
ZOLPIDEM TARTRATE 58 53* 13 41 25
DIAZEPAM 57 40 11 B 42 105
NAMENDA 57 <11 <11 42 44
OXYBUTYNIN CHLORIDE ER 56 <11 <11 44 117
CLOPIDOGREL 56 56 14 44 28
IBUPROFEN 54 <11 <11 46 91
METHADONE HCL 53 <11 <11 S2 47 68
CRESTOR 53 53 13 47 37
OXYBUTYNIN CHLORIDE 52 47* 11 49 84
MIRTAZAPINE 52 <11 <11 49 42
DIOVAN 51 <11 <11 51 59
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.